The Analyzing COVID-19 on a Global Scale: Investigating its Worldwide Ramifications
DOI:
https://doi.org/10.59890/ijasr.v1i2.492Keywords:
BatCoV RaTG13, SARS-CoV-2 genome, coronavirus, vaccination, PCRAbstract
The most recent coronavirus information and updates, including the number of confirmed cases, deaths, and affected countries worldwide, are outlined in this study. There were approximately 700 million confirmed cases and 6 million deaths globally at the time of the study. To manage and prevent the virus from spreading, the World Health Organization (WHO) has established guidelines and recommendations for safety measures like vaccination, wearing face masks, avoiding social situations, maintaining proper hand hygiene, and restricting travel. The emergence of novel virus variants highlights the need for ongoing vigilance and adaptation in public health, and ongoing research has guided the development of effective vaccines and treatments.
References
Adjobimey, T., Meyer, J., Sollberg, L., Bawolt, M., Berens, C., Kovačević, P., & Hoerauf, A. (2022). Comparison of IgA, IgG, and neutralizing antibody responses following immunization with Moderna, BioNTech, AstraZeneca, Sputnik-V.
Johnson and Johnson, and Sinopharm’s COVID-19 vaccines. Frontiers in Immunology, 13, 3094.
Aleem, A., AB, A. S., & Slenker, A. K. (2021). Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19).
Ao, Z., Jing Ouyang, M., Olukitibi, T. A., Warner, B., Vendramelli, R., Truong, T., & Yao, X. (2021). Development and Characterization of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against COVID-19 Delta Variant and Influenza Virus. bioRxiv, 2021-12.
Araf, Y., Akter, F., Tang, Y. D., Fatemi, R., Parvez, M. S. A., Zheng, C., & Hossain, M. G. (2022). Omicron variant of SARS‐CoV‐2: genomics, transmissibility, and responses to current COVID‐19 vaccines. Journal of medicaMedical Virology), 1825-1832.
Archer, S. L., Sharp, W. W., & Weir, E. K. (2020). Differentiating COVID-19 pneumonia from acute respiratory distress syndrome and high altitude pulmonary edema: therapeutic implications. Circulation, 142(2), 101-104.
Asselah, T., Durantel, D., Pasmant, E., Lau, G., & Schinazi, R. F. (2021). COVID-19: Discovery, diagnostics and drug development. Journal of Hepatology, 74(1), 168-184.
Baud, D., Qi, X., Nielsen-Saines, K., Musso, D., Pomar, L., & Favre, G. (2020). Real estimates of mortality following COVID-19 infection. The Lancet infectInfectious Diseases), 773.
Biswas, N., Mustapha, T., Khubchandani, J., & Price, J. H. (2021). The nature and extent of COVID-19 vaccination hesitancy in healthcare workers. Journal of Community Health1244-1251.
Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J. L., Navis, G. J., Gordijn, S. J., ... & van Goor, H. (2020). Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19). The Journal of Pathology, 251(3), 228-248.
Chenchula, S., Karunakaran, P., Sharma, S., & Chavan, M. (2022). Current evidence on the efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review. Journal of Medical Virology, 94(7), 2969-2976.
Cherian, S., Potdar, V., Jadhav, S., Yadav, P., Gupta, N., Das, M., & Team, N. I. C. (2021). SARS-CoV-2 spike mutations, L452R, T478K, E484Q, and P681R, in the second wave of COVID-19 in Maharashtra, India. Microorganisms, 9(7), 1542.
Ciotti, M., Ciccozzi, M., Terrinoni, A., Jiang, W. C., Wang, C. B., & Bernardini, S. (2020). The COVID-19 pandemic. Critical reviews in clinical laboratory sciences, 57(6), 365-388.
Cochrane Haematology Group, Ansems, K., Grundeis, F., Dahms, K., Mikolajewska, A., Thieme, V., & Fichtner, F. (1996). Remdesivir for the treatment of COVID‐19. Cochrane Database of Systematic Reviews, 2021(8).
Crommelin, D. J., Volkin, D. B., Hoogendoorn, K. H., Lubiniecki, A. S., & Jiskoot, W. (2021). The science is there: key considerations for stabilizing viral vector-based Covid-19 vaccines. Journal of Pharmaceutical Sciences, 110(2), 627-634.
Dambha-Miller, H., Hinton, W., Wilcox, C. R., Lemanska, A., Joy, M., Feher, M., & Griffin, S. (2023). Mortality from angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people. Family practice, 40(2), 330-337.
De Almeida-Pititto, B., Dualib, P. M., Zajdenverg, L., Dantas, J. R., De Souza, F. D., Rodacki, M., & Brazilian Diabetes Society Study Group (SBD). (2020). Severity and mortality of COVID-19 in patients with diabetes, hypertension, and cardiovascular disease: a meta-analysis. Diabetology & metabolic syndrome, 12, 1-12.
Felsenstein, S., Herbert, J. A., McNamara, P. S., & Hedrich, C. M. (2020). COVID-19: Immunology and treatment options. Clinical immunology, 215, 108448.
Fernández, A. (2021). Molecular biology clues portray SARS-CoV-2 as a gain-of-function laboratory manipulation of bat CoV RaTG13. ACS Medicinal Chemistry Letters, 12(6), 941-942.
Formeister, E. J., Chien, W., Agrawal, Y., Carey, J. P., Stewart, C. M., & Sun, D. Q. (2021). Preliminary analysis of the association between COVID-19 vaccination and sudden hearing loss using US Centers for Disease Control and Prevention vaccine adverse events reporting system data. JAMA Otolaryngology–Head & Neck Surgery, 147(7), 674-676.
Giannis, D., Ziogas, I. A., & Gianni, P. (2020). Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. Journal of Clinical Virology, 127, 104362.
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., & Krogan, N. J. (2020). A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature, 583(7816), 459-468.
Goudouris, E. S. (2021). Laboratory diagnosis of COVID-19. Jornal de pediatria, 97, 7-12.
Güner, H. R., Hasanoğlu, İ., & Aktaş, F. (2020). COVID-19: Prevention and control measures in the community. Turkish Journal of medicaMedical Sciences), 571-577.
Guo, Y. R., Cao, Q. D., Hong, Z. S., Tan, Y. Y., Chen, S. D., Jin, H. J., & Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military medical research, 7, 1-10.
Hart, J. D., Chokephaibulkit, K., Mayxay, M., Ong-Lim, A. L. T., Saketa, S. T., & Russell, F. M. (2022). COVID-19 vaccine boosters in the Asia-Pacific region in the context of Omicron. The Lancet Regional Health–Western Pacific, 20.
Hashim, M. J., Alsuwaidi, A. R., & Khan, G. (2020). Population risk factors for COVID-19 mortality in 93 countries. Journal of Epidemiology and Global Health), 204.
Hernández‐Huerta, M. T., Mayoral, L. P. C., Navarro, L. M. S., Mayoral‐Andrade, G., Mayoral, E. P. C., Zenteno, E., & Pérez‐Campos, E. (2021). Should RT‐PCR be considered a gold standard in the diagnosis of COVID‐19? Journal of Medical Virology, 93(1), 137.
Hoffmann, M., Arora, P., Groß, R., Seidel, A., Hörnich, B. F., Hahn, A. S., & Pöhlmann, S. (2021). SARS-CoV-2 variants B. 1.351 and P. 1 escape from neutralizing antibodies. Cell, 184(9), 2384-2393.
Hu, B., Guo, H., Zhou, P., & Shi, Z. L. (2021). Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology, 19(3), 141-154.
Hutchins, H. J., Wolff, B., Leeb, R., Ko, J. Y., Odom, E., Willey, J., & Bitsko, R. H. (2020). COVID-19 mitigation behaviors by age group—United States, April–June 2020. Morbidity and Mortality Weekly Report, 69(43), 1584.
Jahanshahlu, L., & Rezaei, N. (2020). A monoclonal antibody as a potential anti-COVID-19. Biomedicine & Pharmacotherapy, 129, 110337.
Jean, S. S., Lee, P. I., & Hsueh, P. R. (2020). Treatment options for COVID-19: The reality and challenges. Journal of Microbiology, immunology, and Infection, 53(3), 436-443.
Jones, I., & Roy, P. (2021). The Sputnik V COVID-19 vaccine candidate appears safe and effective. The Lancet, 397(10275), 642-643.
Jungreis, I., Sealfon, R., & Kellis, M. (2021). SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes. Nature communications, 12(1), 2642.
Karim, S. S. A., & Karim, Q. A. (2021). Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. The Lancet, 398(10317), 2126-2128.
Khan, A. U., Proma, A. A., Akter, M., Rahaman, M. M., & Das, S. (2020). A review of coronavirus disease (COVID-19) epidemic threat for global health in 2020. American Journal of Microbiological Research, 8(2), 57-62.
Khoury, J., Najjar-Debbiny, R., Hanna, A., Jabbour, A., Ahmad, Y. A., Saffuri, A., & Hakim, F. (2021). COVID-19 vaccine–Long-term immune decline and breakthrough infections. Vaccine, 39(48), 6984-6989.
Klein, H., Asseo, K., Karni, N., Benjamini, Y., Nir-Paz, R., Muszkat, M., & Niv, M. Y. (2021). Onset, duration, and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients. Clinical Microbiology and Infection, 27(5), 769-774.
Ko, J. Y., DeSisto, C. L., Simeone, R. M., Ellington, S., Galang, R. R., Oduyebo, T., & Shapiro-Mendoza, C. K. (2021). Adverse pregnancy outcomes, maternal complications, and severe illness among US delivery hospitalizations with and without a coronavirus disease 2019 (COVID-19) diagnosis. Clinical Infectious Diseases, 73(Supplement_1), S24-S31.
Konatham, T. K., Satyanarayana Reddy, K., Masipogu, A., & Vallakeerthi, N. (2020). A Review of viruses that originated from China; SARS, MERS, and COVID-19. World Journal of Pharmaceutical Research, 9(5), 2010-2015.
Lai, D., Cai, Y., Chan, T. H., Gan, D., Hurson, A. N., & Zhang, Y. D. (2022). How to organize travel restrictions in the new future: lessons from the COVID-19 response in Hong Kong and Singapore. BMJ Global Health, 7(2), e006975.
Le, T. T., Andreadakis, Z., Kumar, A., Román, R. G., Tollefsen, S., Saville, M., & Mayhew, S. (2020). The COVID-19 vaccine development landscape. Nat Rev Drug Discov, 19(5), 305-306.
Lopez-Rincon, A., Perez-Romero, C. A., Tonda, A., Mendoza-Maldonado, L., Claassen, E., Garssen, J., & Kraneveld, A. D. (2021). Design of specific primer sets for the detection of B. 1.1. 7, B. 1.351 and P. 1 SARS-CoV-2 variants using deep learning. BioRxiv, 70.
Lotfi, M., Hamblin, M. R., & Rezaei, N. (2020). COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clinica chimica acta, 508, 254-266.
Lu, Q., Zhu, Z., Tan, C., Zhou, H., Hu, Y., Shen, G., & Xie, X. (2021). Changes of serum IL‐10, IL‐1β, IL‐6, MCP‐1, TNF‐α, IP‐10 and IL‐4 in COVID‐19 patients. International Journal of Clinical Practice, 75(9), e14462.
Mehraeen, E., Salehi, M. A., Behnezhad, F., Moghaddam, H. R., & SeyedAlinaghi, S. (2021). Transmission modes of COVID-19: a systematic review. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders), 21(6), 27-34.
Nabi, K. N. (2020). Forecasting COVID-19 pandemic: A data-driven analysis. Chaos, Solitons & Fractals, 139, 110046.
Ng, M. Y., Lee, E. Y., Yang, J., Yang, F., Li, X., Wang, H., & Kuo, M. D. (2020). Imaging profile of the COVID-19 infection: radiologic findings and literature review. Radiology: Cardiothoracic Imaging, 2(1), e200034.
Ornell, F., Moura, H. F., Scherer, J. N., Pechansky, F., Kessler, F. H. P., & von Diemen, L. (2020). The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment. Psychiatry Research, 289, 113096.
Ouassou, H., Kharchoufa, L., Bouhrim, M., Daoudi, N. E., Imtara, H., Bencheikh, N., & Bnouham, M. (2020). The Pathogenesis of coronavirus disease 2019 (COVID-19): evaluation and prevention. Journal of Immunology Research, 2020.
Paterson, R. W., Brown, R. L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., & Zandi, M. S. (2020). The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain, 143(10), 3104-3120.
Qiu, J., Shen, B., Zhao, M., Wang, Z., Xie, B., & Xu, Y. (2020). A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. General psychiatry, 33(2).
Raza, S., Navid, M. T., Zahir, W., Khan, M. N., Awais, M., Yaqub, T., & Rasheed, M. A. (2021). Analysis of the spike proteins suggests pangolin is an intermediate host of COVID-19 (SARS-CoV-2). International Journal of Agriculture and Biology, 25(3).
Rokni, M., Hamblin, M. R., & Rezaei, N. (2020). Cytokines and COVID-19: Friends or Foes? Human vaccines & immunotherapeutics, 16(10), 2363-2365.
Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity, 109, 102433.
Salian, V. S., Wright, J. A., Vedell, P. T., Nair, S., Li, C., Kandimalla, M., & Kandimalla, K. K. (2021). COVID-19 transmission, current treatment, and future therapeutic strategies. Molecular pharmaceutics, 18(3), 754-771.
Salomon, J. A., & Bilinski, A. (2022). Evaluating the performance of Centers for Disease Control and Prevention COVID-19 community levels as leading indicators of COVID-19 mortality. Annals of Internal Medicine, 175(9), 1240-1249.
Santa Cruz, A., Mendes-Frias, A., Oliveira, A. I., Dias, L., Matos, A. R., Carvalho, A., & Silvestre, R. (2021). Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia. Frontiers in immunology, 12, 613422.
Sayampanathan, A. A., Heng, C. S., Pin, P. H., Pang, J., Leong, T. Y., & Lee, V. J. (2021). Infectivity of asymptomatic versus symptomatic COVID-19. The Lancet, 397(10269), 93-94.
Schlick, T., Zhu, Q., Jain, S., & Yan, S. (2021). Structure-altering mutations of the SARS-CoV-2 frameshifting RNA element. Biophysical journal, 120(6), 1040-1053.
Sessa, M., Kragholm, K., Hviid, A., & Andersen, M. (2021). Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines. Expert opinion on drug safety, 20(11), 1451-1453.
Singh, J., Samal, J., Kumar, V., Sharma, J., Agrawal, U., Ehtesham, N. Z., & Hasnain, S. E. (2021). Structure-function analyses of new SARS-CoV-2 variants B. 1.1. 7, B. 1.351, and B. 1.1. 28.1: clinical, diagnostic, therapeutic, and public health implications. Viruses, 13(3), 439.
Singhal, T. (2020). A review of coronavirus disease-2019 (COVID-19). The Indian Journal of Pediatrics, 87(4), 281-286.
Stasi, C., Fallani, S., Voller, F., & Silvestri, C. (2020). Treatment for COVID-19: An overview. European Journal of Pharmacology, 889, 173644.
Sultan, L. R., & Sehgal, C. M. (2020). A review of early experience in lung ultrasound in diagnosing and managing COVID-19. Ultrasound in Medicine & Biology, 46(9), 2530-2545.
Tenforde, M. W., Self, W. H., Naioti, E. A., Ginde, A. A., Douin, D. J., Olson, S. M., & Cass, C. (2021). Sustained effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 associated hospitalizations among adults—United States, March–July 2021. Morbidity and Mortality Weekly Report, 70(34), 1156.
Udomsinprasert, W., Jittikoon, J., Sangroongruangsri, S., & Chaikledkaew, U. (2021). Circulating levels of interleukin-6 and interleukin-10, but not tumor necrosis factor-alpha, as potential biomarkers of severity and mortality for COVID-19: a systematic review with meta-analysis. Journal of Clinical Immunology, 41, 11-22.
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., & Ferguson, N. M. (2020). Estimates of the severity of COVID-19 disease. MedRxiv, 2020-03.
Wang, L., He, W. B., Yu, X. M., Hu, D. L., & Jiang, H. (2020). Prolonged prothrombin time at admission predicts poor clinical outcomes in COVID-19 patients. World Journal of Clinical Cases, 8(19), 4370.
Wang, P., Nair, M. S., Liu, L., Iketani, S., Luo, Y., Guo, Y., & Ho, D. D. (2021). Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7. Nature, 593(7857), 130-135.
Wong, M. K., Brooks, D. J., Ikejezie, J., Gacic-Dobo, M., Dumolard, L., Nedelec, Y., & Van Kerkhove, M. D. (2023). COVID-19 mortality and Progress toward vaccinating older adults—World Health Organization, worldwide, 2020–2022. Morbidity and Mortality Weekly Report, 72(5), 113.
Xu, K., Cai, H., Shen, Y., Ni, Q., Chen, Y., Hu, S., & Li, L. (2020). Management of COVID-19: The Zhejiang experience. Zhejiang da xue xue bao. Yi xue ban= Journal of Zhejiang University. Medical sciences, 49(2), 147-157.
Yager, E. J. (2020). Antibody-dependent enhancement and COVID-19: moving toward acquittal. Clinical Immunology (Orlando, Fla.), 217, 108496.
Yang, L., Liu, S., Liu, J., Zhang, Z., Wan, X., Huang, B., & Zhang, Y. (2020). COVID-19: immunopathogenesis and Immunotherapeutics. Signal transduction and targeted therapy, 5(1), 128.
Zhao, X., Liu, S., Yin, Y., Zhang, T., & Chen, Q. (2022). Airborne transmission of COVID‐19 virus in enclosed spaces: an overview of research methods. Indoor air, 32(6), e13056.
Zhou, H., Yang, J., Zhou, C., Chen, B., Fang, H., Chen, S., & Zhang, L. (2021). A review of SARS-CoV2: compared with SARS-CoV and MERS-CoV. Frontiers in medicine, 8, 628370.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Mustapha Abdulsalam, Khadija Muntaqa Tijjani Usman, Amina Abdulkadir Nurudeen, Fatima Yusuf Muhammad
This work is licensed under a Creative Commons Attribution 4.0 International License.
